Babak moghimi biography definition

          “CAR T-cell therapy is incredibly powerful, but for uses beyond leukemia it has significant barriers,” says.

          I am a pediatric Hematology/Oncology physician specialized in Stem Cell Transplant with focus on immunotherapy and cell therapy..

          Assistant Professor of Clinical Pediatrics

          Is this your profile?

          Click to edit

          Publications

          • CD33-CD123 IF-THEN gating reduces toxicity while enhancing the specificity and memory phenotype of AML-targeting CAR-T cells Blood Cancer Discov. 2024 Dec 03.

            . View in PubMed

          • Impact of FilmArray™ Respiratory Panel testing on the clinical management of pediatric bone marrow transplant patients Eur J Clin Microbiol Infect Dis. 2022 Mar; 41(3):395-405. .

            "CAR T therapy is incredibly powerful, but for solid tumors it has significant barriers," said Dr Babak Moghimi, the lead author.

            View in PubMed

          • Combined immune checkpoint blockade increases CD8+CD28+PD-1+ effector T cells and provides a therapeutic strategy for patients with neuroblastoma Oncoimmunology. 2021 01 04; 10(1):1838140. . View in PubMed
          • Preclinical assessment of the efficacy and specificity of GD2-B7H3 SynNotch CAR-T in metastatic neuroblastoma Nat Commun.

            Roles, Competed in Olympic Games.

          • Roles, Competed in Olympic Games.
          • Babak Moghimi, MD, is a physician-scientist in the Transplantation Cellular.
          • I am a pediatric Hematology/Oncology physician specialized in Stem Cell Transplant with focus on immunotherapy and cell therapy.
          • “CAR T-cell therapy is incredibly powerful, but for uses beyond leukemia it has significant barriers,” says.
          • B Moghimi Dehkordi's 10 research works with citations, including: Necessity of Standard Classification of Occupation by Researches.

            • 2021 01 21; 12(1):511. . View in PubMed

          • High-Affinity GD2-Specific CAR T Cells Induce Fatal Encephalitis in a Preclinical Neuroblastoma Model Cancer Immunol Res. 2018 01; 6(1):36-46.